Myriad Genetics, Inc. earnings per share and revenue

MYGN earnings per share for the last quarter are 0.04 USD whereas the estimation was 0.01 USD which accounts for 182.35% surprise. Company revenue for the same period amounts to 196.60 M USD despite the estimated figure of 194.80 M USD. Estimated earnings per share for the next quarter are -0.10 USD, and revenue is expected to reach 193.51 M USD. Also watch annual changes over time to get a bigger picture of MYGN earnings per share and revenue dynamics.